HYPER-CVAD regimen

WikiDoc Resources for HYPER-CVAD regimen
Articles
Most recent articles on HYPER-CVAD regimen Most cited articles on HYPER-CVAD regimen Review articles on HYPER-CVAD regimen Articles on HYPER-CVAD regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on HYPER-CVAD regimen Images of HYPER-CVAD regimen Photos of HYPER-CVAD regimen Podcasts & MP3s on HYPER-CVAD regimen Videos on HYPER-CVAD regimen
Evidence Based Medicine
Cochrane Collaboration on HYPER-CVAD regimen Bandolier on HYPER-CVAD regimen TRIP on HYPER-CVAD regimen
Clinical Trials
Ongoing Trials on HYPER-CVAD regimen at Clinical Trials.gov Trial results on HYPER-CVAD regimen Clinical Trials on HYPER-CVAD regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on HYPER-CVAD regimen NICE Guidance on HYPER-CVAD regimen NHS PRODIGY Guidance FDA on HYPER-CVAD regimen CDC on HYPER-CVAD regimen
Books
Books on HYPER-CVAD regimen
News
HYPER-CVAD regimen in the news Be alerted to news on HYPER-CVAD regimen News trends on HYPER-CVAD regimen
Commentary
Blogs on HYPER-CVAD regimen
Definitions
Definitions of HYPER-CVAD regimen
Patient Resources / Community
Patient resources on HYPER-CVAD regimen Discussion groups on HYPER-CVAD regimen Patient Handouts on HYPER-CVAD regimen Directions to Hospitals Treating HYPER-CVAD regimen Risk calculators and risk factors for HYPER-CVAD regimen
Healthcare Provider Resources
Symptoms of HYPER-CVAD regimen Causes & Risk Factors for HYPER-CVAD regimen Diagnostic studies for HYPER-CVAD regimen Treatment of HYPER-CVAD regimen
Continuing Medical Education (CME)
CME Programs on HYPER-CVAD regimen
International
HYPER-CVAD regimen en Espanol HYPER-CVAD regimen en Francais
Business
HYPER-CVAD regimen in the Marketplace Patents on HYPER-CVAD regimen
Experimental / Informatics
List of terms related to HYPER-CVAD regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Hyper-Cyclophosphamide-Vincristine-Adriamycin-Dexamethasone regimen

Overview

HYPER-CVAD regimen refers to a regimen consisting of cyclophosphamide, vincristine, Doxorubicin (Adriamycin), and dexamethasone used to treat some forms of leukemia, non-Hodgkin's lymphoma, lymphoblastic lymphoma , and multiple myeloma.

Regimen

CCyclophosphamide

VVincristine (Oncovin)

ADoxorubicin (Adriamycin, Hydroxydaunorubicin)

DDexamethasone

Indications

• Multiple myeloma.